168 related articles for article (PubMed ID: 34974784)
1. The diagnostic value of serum YKL-40 in endometrial cancer: a meta-analysis.
Qin R; Liao M; Qin W; Wang J; Zheng F; Ma N; Zhao Y; Qin A
Biomarkers; 2022 May; 27(3):215-221. PubMed ID: 34974784
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of circulating YKL-40 in endometrial carcinoma patients: a meta-analysis of seven related studies.
Cheng D; Sun Y; He H
Med Oncol; 2014 Dec; 31(12):326. PubMed ID: 25412935
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma.
Liu J; Han L; Sun Q; Li Y; Niyazi M
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():404-411. PubMed ID: 32711295
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
Gao J; Fan YZ; Gao SS; Zhang WT
Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
[TBL] [Abstract][Full Text] [Related]
5. Human epididymis protein 4 in endometrial cancer: A meta-analysis.
Li LM; Zhu YX; Zhong Y; Su T; Fan XM; Xi Q; Li MY; Fu J; Tan H; Liu S
Clin Chim Acta; 2018 Jul; 482():215-223. PubMed ID: 29630870
[TBL] [Abstract][Full Text] [Related]
6. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
Chen Y; Ren YL; Li N; Yi XF; Wang HY
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
[TBL] [Abstract][Full Text] [Related]
7. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer.
Fan JT; Si XH; Liao Y; Shen P
Arch Gynecol Obstet; 2013 Jan; 287(1):111-5. PubMed ID: 22945838
[TBL] [Abstract][Full Text] [Related]
9. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
Huang GQ; Xi YY; Zhang CJ; Jiang X
Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
[No Abstract] [Full Text] [Related]
10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
11. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
Yang Y; Yan S; Tian H; Bao Y
Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
[TBL] [Abstract][Full Text] [Related]
12. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
13. Serum 14-3-3η is a Marker that Complements Current Biomarkers for the Diagnosis of RA: Evidence from a Meta-analysis.
Wu Y; Dai Z; Wang H; Wang H; Wu L; Ling H; Zhu Y; Ye D; Wang B
Immunol Invest; 2022 Jan; 51(1):182-198. PubMed ID: 32967487
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of shear wave elastography for endometrial cancer: A meta-analysis.
Bian J; Li J; Liu Y
Medicine (Baltimore); 2023 Jan; 102(4):e32700. PubMed ID: 36705368
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Serum IgG4 for IgG4-Related Disease: A PRISMA-compliant Systematic Review and Meta-analysis.
Hao M; Liu M; Fan G; Yang X; Li J
Medicine (Baltimore); 2016 May; 95(21):e3785. PubMed ID: 27227950
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic accuracy of artery peak velocity variation measured by bedside real-time ultrasound for prediction of fluid responsiveness: a Meta-analysis].
Pei Y; Yang Y; Feng Y; He S; Zhou J; Jiang H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):99-105. PubMed ID: 32148240
[TBL] [Abstract][Full Text] [Related]
17. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
19. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
Lin JY; Qin JB; Li XY; Dong P; Yin BD
Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
